F8 ENT (08347) announced its financial results for the six months ended September 30, 2025. The company reported revenue of HK$135 million, a decrease of 26.8% year-on-year. However, net profit rose to HK$3.45 million, marking an 82% increase compared to the same period last year. Basic earnings per share stood at HK2.51 cents. The growth in net profit was primarily attributed to reduced cost of sales and lower operational expenses.